Background-Atherosclerotic plaques progress in a highly individual manner. The purposes of the Prediction of Progression of Coronary Artery Disease and Clinical Outcome Using Vascular Profiling of Shear Stress and Wall Morphology (PREDICTION) Study were to determine the role of local hemodynamic and vascular characteristics in coronary plaque progression and to relate plaque changes to clinical events. Methods and Results-Vascular profiling, using coronary angiography and intravascular ultrasound, was used to reconstruct each artery and calculate endothelial shear stress and plaque/remodeling characteristics in vivo. Three-vessel vascular profiling (2.7 arteries per patient) was performed at baseline in 506 patients with an acute coronary syndrome treated with a percutaneous coronary intervention and in a subset of 374 (74%) consecutive patients 6 to 10 months later to assess plaque natural history. Each reconstructed artery was divided into sequential 3-mm segments for serial analysis. One-year clinical follow-up was completed in 99.2%. Symptomatic clinical events were infrequent: only 1 (0.2%) cardiac death; 4 (0.8%) patients with new acute coronary syndrome in nonstented segments; and 15 (3.0%) patients hospitalized for stable angina. Increase in plaque area (primary end point) was predicted by baseline large plaque burden; decrease in lumen area (secondary end point) was independently predicted by baseline large plaque burden and low endothelial shear stress. Large plaque size and low endothelial shear stress independently predicted the exploratory end points of increased plaque burden and worsening of clinically relevant luminal obstructions treated with a percutaneous coronary intervention at follow-up. The combination of independent baseline predictors had a 41% positive and 92% negative predictive value to predict progression of an obstruction treated with a percutaneous coronary intervention. Conclusions-Large plaque burden and low local endothelial shear stress provide independent and additive prediction to identify plaques that develop progressive enlargement and lumen narrowing. Clinical Trial Registration-URL: http:www.//clinicaltrials.gov.
geometry of the artery associated with its natural curvature and the acquired presence of focal atherosclerotic obstructions. Mechanical forces, in general, and fluid shear stress, in particular, elicit a large number of humoral, metabolic, and structural responses in endothelial cells. [3] [4] [5] The response of a number of genes sensitive to local low endothelial shear stress (ESS) leads to creation of a raised plaque; subsequent hemodynamic forces created by the enlarging plaque may lead to a cycle of progressive atherogenesis, 3, 6, 7 which may culminate in plaque rupture that may become clinically manifest as obstructive thrombus 6, 8 or rapid progression of a fixed obstruction. 9 Identification of an early coronary atherosclerotic plaque likely to acquire high-risk characteristics and precipitate a new coronary event may allow for development of preemptive strategies to avert adverse events. The recent Providing Regional Observations to Study Predictors of Events in the Coronary Tree (PROSPECT) Study 10 demonstrated that coronary lesions responsible for new cardiac events in patients following a percutaneous coronary intervention (PCI) for an acute coronary syndrome (ACS) were associated with large plaque burden, a small lumen area, thin-cap fibroatheroma (TCFA) morphology, as assessed by intravascular ultrasound (IVUS), and minimal obstruction by angiography. This natural history study was limited, however, by acquisition of vascular characteristics at only a single point in time, and pathobiological mechanisms potentially responsible for ongoing and progressive plaque instability, such as local ESS, were not investigated.
The purposes of the Prediction of Progression of Coronary Artery Disease and Clinical Outcome Using Vascular Profiling of Shear Stress and Wall Morphology (PREDICTION) Study were to identify the detailed coronary hemodynamic and plaque characteristics in high-risk patients following a PCI for an ACS, to follow the serial natural history of the plaques over a 6-to 10-month period in a large number of consecutive patients, and to investigate whether high-risk lesions likely to rupture and cause an ACS or rapid progression of an obstruction could be identified early in its natural history.
Methods

Study Design
The PREDICTION Study was designed as both an anatomic natural history study and an event-attribution study. Patients with an ACS undergoing PCI for a culprit lesion were enrolled and underwent coronary vascular profiling (VP), as described below, at the time of the index catheterization procedure. A large subset of consecutive, unselected patients underwent follow-up VP after 6 to 10 months to assess anatomic natural history and antecedent vascular characteristics responsible for the natural history. All patients had clinical follow-up at 1 year. The study was performed in Japanese clinical sites because Japanese patients routinely undergo follow-up catheterization and IVUS 6 months after successful PCI for an ACS, and this clinical practice facilitated performance of a large natural history study.
Inclusion criteria included age Ͼ18 years, presentation with an ACS, CAD with at least 1 coronary segment requiring PCI according to usual clinical indications, and at least 1 vessel suitable for IVUS not planned for PCI. Exclusion criteria included heart failure New York Heart Association class III/IV, unstable clinical status, left main disease or 3-vessel disease, significant coronary calcification precluding IVUS evaluation, renal failure such that additional contrast material would be contraindicated, clinically significant valvular disease, and life expectancy Ͻ12 months.
Study Methods
Detailed ESS and plaque/arterial wall characteristics were identified with use of VP methods combining intracoronary IVUS and biplane coronary angiography to represent the artery accurately in 3D space and to measure flow, as previously described, 11, 12 and presented in detail in the online-only Data Supplement. In brief, the 3D anatomy of the artery was reconstructed from digitized radiofrequency IVUS signals and two planes of coronary angiography. The arterial lumen and outer vessel wall were reconstructed from digitized and segmented end-diastolic IVUS frames. A structured grid utilizing a body-fitted coordinate system was used to represent the lumen volume. Coronary blood flow was calculated directly from the time required for the previously calculated, true 3D volume of blood contained within the arterial section to be displaced by radio-opaque material during a contrast injection. The detailed intravascular flow characteristics were obtained by solving the transport equations governing the conservation of mass and momentum (Phoenics, CHAM, England). 11 The ESS at the luminal surface of the artery was calculated as the product of viscosity (calculated from the measured hematocrit) and the gradient of blood velocity at the wall. The 3D geometry of the outer vessel wall (area within the external elastic membrane [EEM]) was recreated in a manner similar to that described for the lumen geometry. The 3D geometry of the plaque (plaque plus media thickness) was taken as the difference between the outer vessel wall and the lumen. 13 The processes of data acquisition and analysis are highly reproducible. 12 
Study Assessments
We divided the entire reconstructed artery into consecutive 3-mm segments starting at the ostium. We chose 3-mm segments because this length was methodologically reliable and would also accurately reflect the local hemodynamic and plaque characteristics, and the heterogeneous and highly focal changes occurring within the plaque over time, as well. Within each 3D segment we assessed local ESS, plaque characteristics, and vascular remodeling. 14 The same coronary artery segments were evaluated at the time of the follow-up catheterization 6 to 10 months later to determine the change in vascular characteristics. Assurance that the arterial segments to be measured were identical at the initial and the follow-up procedures was accomplished by using fixed anatomic landmarks, primarily multiple arterial branches, as reference fiducial points.
Coronary artery natural history outcomes were analyzed by utilizing a variety of different approaches to represent different magnitudes of CAD progression. (1) Each 3-mm segment was evaluated to determine the effect of the baseline local ESS and plaque characteristics (as continuous variables) on the change in vascular outcome variables (as continuous variables) in the same segment. (2) We analyzed the natural history of obstructions at baseline, because arterial areas with a lumen narrowing at baseline may be particularly likely to exhibit worsening obstruction in follow-up. We analyzed those arterial areas of 5 sequential 3-mm segments at baseline within which a discrete luminal narrowing ("throat") was present in the middle, surrounded by two 3-mm segments with progressive narrowing on either side of the throat. Each two 3-mm segments proximal (upstream) to the throat had to exhibit progressive decrease in lumen area Ͼ0.1 mm 2 in comparison with the preceding 3-mm segments, and each 3-mm segment distal (downstream) to the throat had to exhibit progressive increase in lumen area Ͼ0.1 mm 2 in comparison with the preceding 3-mm segments. These baseline lumen narrowings were evaluated for change in obstruction at follow-up, and the baseline ESS was investigated to determine its role in the outcome. (3) We identified those patients who underwent a PCI during the follow-up because of new clinical symptoms or substantial worsening of the luminal obstruction, and we investigated the antecedent vascular characteristics responsible for the clinically relevant change in lumen obstruction.
The PREDICTION Study is an observational natural history study. The primary end point when the study was designed in 2006 was change in plaque area, but we also identified a variety of secondary exploratory end points. We include plaque burden as an end point to reflect a combined end point of both plaque and EEM areas.
Statistical Analysis
Categorical variables are presented as counts and percentages; continuous variables are summarized as meanϮSEM or median and interquartile range as appropriate. Several statistical methods were used to correct for systematic error (nonindependence of observations) introduced by the clustering of multiple arterial 3-mm segments or lumen narrowings within patients. First, to investigate the association of continuous response variables (eg, change in plaque burden) with categorical variables (eg, baseline ESS category), mixed-effects ANOVA with the patient and artery designated as random effects was used. Probability values were adjusted for multiple comparisons with the use of the Scheffé method. Second, to investigate the relationship between continuous response variables and continuous predictors (eg, ESS magnitude), linear mixed modeling was used. Third, to investigate the association of binary anatomic outcomes (eg, progressive decrease in lumen area, worsening luminal narrowing treated with PCI) with baseline variables, mixed-effects logistic regression was implemented. Baseline variables associated with anatomic outcomes on univariable analysis at P level Ͻ0.1 were considered for entry in the respective multivariable models, and final selection of independent predictors was performed with a backward-stepping algorithm (criterion for retention: PϽ0.1). In logistic regression modeling, cut points for dichotomizing continuous anatomic variables were selected by receiver operator characteristic analysis which best predicted each outcome (receiver operator characteristic criterion: max[sensitivityϩspecificity]). All statistical tests were 2-tailed, and an ␣-level of 0.05 was used to determine statistical significance. All analyses were performed with Stata 10.0 (StataCorp LP, College Station, TX) and SPSS 17.0 (SPSS Inc, Chicago, IL).
The study was approved by the institutional review board at each hospital, and each patient gave written informed consent.
Results
Enrollment was initiated on April 7, 2007 , and the last subject follow-up visit was on October 18, 2010. Five hundred six subjects were enrolled at 17 clinical sites in Japan. The index ACS event included an ST-elevation myocardial infarction in 291 patients (57.5%), non-ST-elevation myocardial infarction in 60 patients (11.9%), and unstable angina in 155 patients (30.6%). One-year follow-up was completed in 502 (99.2%) patients. Two patients (0.4%) were lost to follow-up, and 2 patients (0.4%) withdrew consent to participate.
Baseline VP data were obtained in all enrolled patients and were analyzable for 496 (98.0%) patients; a total of 1341 arteries were analyzable (2.7 arteries/patient). Follow-up VP data for serial anatomic natural history analyses were obtained in 374 (74%) consecutive patients. Baseline and follow-up VP data were analyzable for 329 (88.0%) of the 374 patients, including VP data from 824 pairs of arteries.
The reconstructed coronary arteries (mean length per artery, 47.6Ϯ0.44 mm) were divided into consecutive 3-mm-length segments (19 875 3-mm segments; 13 788 3-mm segments in native areas). Each segment was characterized by local predominant ESS value (defined as the minimum averaged ESS value over a 90°arc in each 3-mm segment), plaque and lumen area, plaque burden (plaque area/EEM area), and remodeling pattern. For analysis of serial anatomic changes, each arterial segment at baseline was compared with the identical segment at follow-up (8137 3-mm segments in native areas with available baseline and follow-up VP data).
This report focuses on the natural history and outcomes of the native (nonstented) coronary segments.
Patient Demographics
The patient characteristics are presented in Table 1 . A majority of patients had substantial coronary risk factors, but only 59 (11.7%) had a history of previous CAD. Blood pressure at baseline was well controlled, and fasting lipids were modestly elevated. Cardiac risk, assessed by C-reactive protein, was low. At hospital discharge, most patients were on dual-antiplatelet therapy and routine vasculoprotective therapies ( Table 2) .
Safety of VP Procedures
Eight hundred ninety-five VP procedures were performed. There were 5 complications (0.6%): coronary artery dissection in 3 and transient neurological deficit in 2 patients. There were no long-term consequences from these complications, and hospital stay was not prolonged. 
Effect of Baseline Vascular Characteristics on Vascular Outcomes at Follow-Up in Each 3-mm Segment
Primary End Point: Change in Plaque Area
Plaque area increase at follow-up, after adjustment for the baseline plaque area, was independently associated with baseline large plaque burden, lumen area, and excessive expansive remodeling (Table 3 and online-only Data Supplement Table I ). Using baseline ESS as a categorical variable based on terciles, low ESS was not associated with a change in plaque area ( Figure 1A ).
Secondary End Point: Change in Lumen Area
Lumen area decrease, after adjustment for baseline lumen area, was independently associated with baseline large plaque burden, low ESS, excessive expansive remodeling, and distal location of the segment (Table 3) . Baseline low ESS as a categorical variable was associated with a significant decrease in lumen area ( Figure 1B ).
Exploratory End Point: Change in Plaque Burden
Plaque burden increase, after adjustment for baseline plaque burden, was independently associated with baseline low ESS, excessive expansive remodeling, large lumen area, and more proximal location of the segment (Table 3) . With use of ESS as a categorical variable, baseline low ESS was associated with a significant increase in plaque burden ( Figure 1C ).
Natural History of Baseline Discrete Luminal Narrowings Based on Local Vascular Characteristics
The majority of lumen obstructions (53%) at follow-up originated from areas with preexisting mild lumen narrowing at baseline. In these baseline narrowings, ESS was primarily moderate proximal to the throat; high just proximal to, and at, the throat; and low distal to the throat ( Figure 2 ). Low ESS distal to the throat was significantly associated with different magnitudes of worsening of luminal area obstruction at follow-up ( Figure 3 ).
Natural History of Clinically Relevant Luminal Obstructions Treated With a PCI at Follow-Up
PCI was performed in follow-up in 59 native lesions in 53 patients (10.5%) either for development of a new clinical event or because of identification of a significantly worsening obstruction in a patient who underwent routine follow-up coronary angiography (Tables 4 to 6 , online-only Data Variables entered in the multivariable model: (A) change in plaque area: ESS, lumen area, plaque area, plaque burden, and remodeling pattern; (B) change in lumen area: ESS, lumen area, plaque burden, longitudinal arterial location, and remodeling pattern; (C) change in plaque burden: ESS, lumen area, plaque area, plaque burden, longitudinal arterial location and remodeling pattern. ESS indicates endothelial shear stress.
*The results for change in plaque area are presented without removing the primary variable of interest (ie, ESS), which was not significant, from the backward stepwise process of the multivariable analysis.
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Supplement Table II , and Figures 4 and 5) . New clinical events consisted of a new ACS in 13 patients (2.6%), which occurred in a native portion of the coronary artery in only 4 patients (0.8%); and worsening stable angina in 15 patients (3%), which occurred in a native segment in 10 patients (2%). Thirty-nine patients (7.8%) had a PCI performed in the absence of symptoms because a worsening native luminal obstruction was observed at the time of the routine follow-up cardiac catheterization (luminal %diameter stenosis measured by quantitative coronary angiography changed from 42.4Ϯ1.6% at baseline to 58.6Ϯ1.5% at follow-up; PϽ0.001). Independent vascular predictors of baseline substantial luminal narrowings (ie, minimal lumen area Ͻ6 mm 2 , which corresponded approximately to the lower tercile of lumen area) treated with PCI for lesion progression or occurrence of symptoms during follow-up were large plaque burden and low ESS (Tables 5 and 6, Figure 4 ). There was no significant relationship between plaque burden at the throat and ESS distal to the throat.
The positive predictive value of baseline vascular characteristics to identify a lesion that progressed clinically at follow-up rose from 22% if only large plaque burden was present to 41% if both large plaque burden and low ESS were present ( Figure 5 ). Negative predictive value remained high if both large plaque burden and low ESS were absent. One hundred ten patients (22.3%) had at least 1 substantial luminal narrowing with large plaque burden at baseline, 50 patients (10.0%) had a substantial luminal narrowing with low ESS at baseline, and 31 patients (6.2%) had a substantial luminal narrowing with both large plaque burden and low ESS.
There was no significant, meaningful association of clinical characteristics at baseline and subsequent vascular change (online-only Data Supplement Tables III and IV) .
Analysis of Clinical Outcomes
Clinical events were infrequent during the 1-year followup (Table 7) . There were a total of 7 deaths (1.4%) and only 1 (0.2%) cardiac death. An ACS occurred in 13 patients (2.6%; 4 patients [0.8%] with the culprit segment in a native vessel area). Hospitalization for worsening stable angina occurred in 15 patients (3.0%; 7 patients [0.8%] with the culprit segment in a native vessel area; 3 patients [0.6%] with both a native and a stented segment treated with revascularization).
There were too few patients with symptomatic clinical events to make meaningful statistical inferences between baseline vascular characteristics and symptomatic clinical outcome events.
Discussion
The PREDICTION Study is unique in that it presents the largest and most comprehensive serial anatomic natural history study of coronary atherosclerosis ever performed and used innovative methodologies to investigate potential pathophysiological mechanisms responsible for CAD progression. The goal of these natural history investigations in consecutive patients with highrisk CAD was to identify the early plaque and arterial wall characteristics that precede the subsequent progression of lesions leading to acute plaque rupture or accelerated luminal obstruction. Our multi-tiered natural history analyses indicate that plaque burden is the most powerful predictor of plaque progression and luminal obstruction and that low ESS provides substantial additive independent prognostication. The combination of the independent baseline predictors of plaque burden and low ESS had a 41% positive predictive value to predict clinically relevant obstruction progression treated with PCI, but the com- bination of these vascular characteristics at baseline was infrequent (6%). Symptomatic clinical events were uncommon in these patients whose disease was well controlled following an ACS, and lack of statistical power precluded analyses to investigate the role of vascular characteristics at baseline to predict new symptomatic clinical events.
The changes in coronary plaque and arterial remodeling observed in the PREDICTION Study, and the prominent role of local ESS in the atherogenic processes associated with those changes in coronary anatomy, are remarkably similar to the observations in the atherosclerotic pig model 2, 7, 15 and small pilot studies in humans. 16, 17 In the diabetic, hypercholesterolemic pig, low ESS was an independent predictor of the development of high-risk TCFAs, and the magnitude of the atherogenic phenotype was inversely related to the magnitude of local ESS. 7, 15, 18 The magnitude of progression of coronary lesions we observed in humans in the PREDICTION Study was not as marked as the progression observed in the pig model, but the pigs were rendered diabetic and intensely hypercholesterolemic (mean serum cholesterol 611Ϯ28 mg/dL), and the duration of follow-up was relatively prolonged. 7, 15 The central proatherogenic role of low ESS in humans is underscored ; nϭ86) . B, Decrease in lumen area Ͼ3.6 mm 2 (10th percentile; nϭ40). C, Decrease in lumen area Ͼ4.7 mm 2 (5th percentile; nϭ20). The 3 ESS categories (low, Ͻ1 Pa; moderate, 1-1.7 Pa; high, Ͼ1.7 Pa) were derived from the terciles of the baseline ESS frequency distribution in 3-mm segments. Probability values are for testing the independence between ESS category (3 groups) and the binary outcome. ESS indicates endothelial shear stress.
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by the observation in the PREDICTION Study that baseline low ESS was an independent predictor responsible for plaque progression and worsening luminal obstruction both in the routine natural history of CAD and in the development of clinically relevant lesions treated with PCI. This relationship between local low ESS and atherosclerosis is particularly impressive, because these coronary patients were followed clinically over a brief 12-month follow-up period (and assessment of anatomic natural history was performed only 6 -10 months after the ACS), they were aggressively managed with vasculoprotective agents, and their cardiovascular risk was low. Baseline large plaque burden and local low ESS were independently associated at follow-up with an increase in plaque burden and decrease in lumen area, and clinical worsening of luminal obstruction treated with a PCI, as well. Local low ESS environment may lead to plaque development, progression, and formation of rupture-prone TCFA, 2,7,15 which initially may not obstruct the lumen, but may rupture and precipitate either a new ACS or rapid progression of a fixed plaque. Plaque progression may have occurred in these regions as a result of intraplaque hemorrhage due to subclinical plaque rupture or disruption of intraplaque vasa vasorum, associated with consequent fibrosis and worsening luminal obstruction. 9, 19, 20 Plaque progression with a decrease in lumen and EEM area may also result from a more direct phenotypic expression of fibrosis and scarring.
We did not observe that baseline high ESS was associated with plaque progression or progressive luminal obstruction. Other investigators have suggested that high ESS may promote transformation of a plaque to a high-risk phenotype. 21, 22 Small studies have observed that plaque rupture in the coronary and carotid circulations may be related to areas of high ESS. 23, 24 We observed very few ACS events in our patients, despite the presence of substantial traditional risk factors and a recent ACS. This relatively benign outcome may be due to the effective vasculoprotective treatments provided to these patients or may reflect the relatively low genetic cardiovascular risk of the Japanese population in comparison with a Western population. 25 Although we did not observe an effect of systemic risk factors on coronary anatomic outcomes, local factors are only important in the context of the presence of systemic risk factors. Recent studies suggest that high-risk plaque characteristics in the carotid artery may be associated with adverse vascular outcomes in other vascular territories. 26 Although low ESS was an independent predictor of plaque burden increase in follow-up, we found that low ESS did not independently predict plaque area increase. The majority of patients in the PREDICTION Study were statin naive before their index coronary event and were administered statins only after their presentation with an ACS. There may have been global regression of atherosclerotic plaque area from the initiation of statins during the follow-up period 27 ( Figure 1A) , and an additional effect of plaque morphology change or EEM shrinkage from local low ESS and associated pathobiology, as well, manifesting as an associated increase in plaque burden and decrease in lumen area ( Figure 1C ).
The observations in the PREDICTION Study are complementary to the recent observations in the PROSPECT Study and provide new mechanistic insights that may elucidate the underlying pathobiology of plaque progression and the development of clinical events. In PROSPECT, 697 patients with an ACS underwent 3-vessel coronary angiography and IVUS imaging after PCI. 10 Multivariable analysis indicated that nonculprit lesions associated with subsequent major adverse cardiovascular events were characterized at baseline by large plaque burden (Ն70%), small minimal luminal area (Յ4.0 mm 2 ), and appearance of a TCFA by radiofrequency IVUS. The hazard ratio for major adverse cardiovascular events at 3 years was high (11.05) if all 3 lesion character- Native area 39 (7.8%) 44
Data on patient classification are not mutually exclusive. PCI indicates percutaneous coronary intervention; 3D, 3-dimensional.
*A total of 59 native areas and 96 previously stented areas (in-stent restenosis or thrombosis) were treated with PCI at follow-up.
†Substantial obstruction progression defined as: (1) lumen area decrease Ͼ1.8 mm 2 or Ͼ20% by 3D-model-based measurements in cases with available baseline and follow-up vascular profiling data, and (2) lumen diameter decrease Ͼ20% by angiography in cases without available follow-up vascular profiling data. istics were present at baseline, but only 4.2% of patients manifested these criteria. Assessment of local ESS was not performed in PROSPECT. As in PROSPECT, only 6% of PREDICTION patients manifested the highest risk lesion profile of large plaque burden and low ESS, but these patients had a 41% incidence of PCI for clinically relevant obstructions. We speculate that the small proportion (3.3%) of plaques with baseline large plaque burden that progressed to cause cardiac events in PROSPECT were those plaques exposed to a low ESS environment, which stimulated progressive inflammation and atherogenesis, culminating in an abrupt luminal change.
Although plaque characterization and estimation of TCFA by radiofrequency IVUS analyses were not available in the PREDICTION Study, large plaque burden was an independent predictor of an adverse outcome in both PREDICTION and PROSPECT. In PREDICTION, there was no relationship between plaque burden and low ESS. The variable of local ESS, uniquely available in the PREDICTION Study, provided substantial independent incremental predictive insight, with the combined presence of low ESS and large plaque burden having a positive predictive value of 41% to identify lesions at baseline likely to require PCI in the next year.
Limitations
The study is limited by the small number of clinical events that occurred in the 1-year follow-up. Many of the clinical events were also primarily asymptomatic and consisted of significant lumen progression treated with PCI. There were few patients with hard ischemic end points. There were only 14 (3%) symptomatic clinical events (related to native segments) in the 1-year follow-up. Furthermore, a number of the culprit lesions in native areas responsible for clinical events were either proximal or distal to the IVUS acquisition pullback and thus not available for detailed VP investigation (proximal, nϭ4; distal, nϭ7; left main coronary artery, nϭ3; VP data not available or usable, nϭ4). We are also limited by not having radiofrequency IVUS characterization of plaque constituents available, although the accuracy of the histological correlation of such characterization has recently been called into question. 28, 29 Our predictive analyses use both continuous and categorical baseline variables, because the continuous variables are essential to prove the pathobiological relationship between baseline vascular characteristics and outcomes, but the categorical variables, derived either by nonbiased terciles or cut points determined by receiver operator characteristic analyses, provide a way to compare the quantitative relationships we observed to the relationships in similar studies performed by investigators who use categorical baseline variables. 2, [21] [22] [23] We emphasize that this study is a natural history study, and our conclusions are primarily exploratory. All of our analyses have been prespecified, but some of the specific threshold values of ESS, plaque area/burden, and lumen narrowings were determined post hoc empirically within the PREDICTION data set. In addition, all patients were post-PCI for an ACS, and we do not know how the findings translate to asymptomatic or stable patients.
In summary, the PREDICTION Study demonstrated that routine 3-vessel IVUS can be safely performed in high-risk patients following successful PCI for an ACS, and that progression of plaque burden and luminal obstruction can be predicted on the basis of the presence of substantial plaque and low ESS at baseline. Most clinical events in follow-up in this population consisted of either asymptomatic or symptomatic progressive luminal narrowing with stable symptoms; ACS events were very infrequent. It remains to be confirmed whether early identification of high-risk lesions is enhanced by determination of local ESS and whether such insights will be clinically useful to guide patient management. 
